Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice

Keyphrases

• Japanese Adults 100%
• Type 2 Diabetes Mellitus (T2DM) 100%
• Routine Clinical Practice 100%
• Multicenter Observational Study 100%
• Adverse Drug Reaction 100%
• Tofogliflozin 100%
• Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i) 66%
• Adverse Events 50%
• Weight Loss 33%
• Hemoglobin A1c (HbA1c) 33%
• 95% Confidence Interval 33%
• Japan 16%
• Prospective Observational Study 16%
• Mechanism of Action 16%
• High Incidence 16%
• Medical Institutions 16%
• Type 2 Diabetic Patients 16%
• Nave 16%
• Unique Mechanism 16%
• Hypoglycemia 16%
• Glycated Hemoglobin A1c 16%
• Urinary Tract Infection 16%
• June 2014 16%
• Adult Type 16%
• Postprandial Hyperglycemia 16%
• Fasting Hyperglycemia 16%
• HbA1c Target 16%
• Reaction Characteristics 16%
• Volume Depletion 16%
• Genital Tract Infection 16%
• Investigator-initiated Studies 16%

Medicine and Dentistry

• Observational Study 100%
• Maturity Onset Diabetes of the Young 100%
• Adverse Drug Reaction 100%
• Tofogliflozin 100%
• Hemoglobin A1c 66%
• Cotransporter 66%
• Adverse Event 50%
• Hypoglycemia 16%
• Urinary Tract Infection 16%
• Glycated Hemoglobin 16%
• Postprandial Hyperglycemia 16%
• Genital Tract Infection 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Observational Study 100%
• Adverse Drug Reaction 100%
• Maturity Onset Diabetes of the Young 100%
• Tofogliflozin 100%
• Cotransporter 66%
• Hemoglobin A1c 66%
• Adverse Event 50%
• Hypoglycemia 16%
• Hyperglycemia 16%
• Urinary Tract Infection 16%
• Glycosylated Hemoglobin 16%
• Genital Tract Infection 16%